Cell Biology Webinars
Cell Biology Webinars
Join Daniel Merriman, Femi Egbebi and Krzysztof Inglot for a presentation on research solutions offered by Thermo Fisher Scientific regarding cell culture analysis, spectrometry, and other topics within the biopharma field.
Scientists can now interrogate cellular biology and cell-to-cell interactions in previously unachievable ways, gaining deeper insight and advancing innovative strategies for targeting cancer.
Deriving deeper biological insight & improving productivity in immune-cell biology
Despite exciting recent developments in neuroscience, identifying novel, truly effective treatments for patients with neurological and psychiatric conditions remains highly challenging.
A growing body of evidence suggests that more relevant, translational observations can be made using 3D microtissues and organoids as compared to 2D monolayer cell culture.
How the use of enhanced data analytics and cell models, has led to the evolution of the IncuCyte® real-time immune cell killing application.
Cell migration and invasion processes play a role in many normal and pathological cellular processes. One of these pathological processes is tumor metastasis. In vitro assays are an excellent way to study both 2D and 3D cell movements to help you better understand cancer cell metastasis.
Our new cell-by-cell analysis module allows users to ‘count and classify’ heterogeneity in cell populations over time.
Monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs) are widely used biological therapeutics.
Biomedical researchers are increasingly using advanced human cell models for translational biology and therapeutic discovery studies.
Mechanical stress, stretching of muscles or shear stress in blood vessels and kidneys for example, is important to the physiological functioning of many organs.
Stem cell therapies begin to enter the clinic, and their quality and safety depends on raw materials used in their production.
How recombinant human albumin can increase cell viability and provide consistent performance
In this presentation, Bruker Daltonics shows how PASEF, implemented on the Bruker timsTOF Pro, can be applied to HCP analysis.
Bioluminescence resonance energy transfer has been long established as a principal method to monitor dynamic protein-protein interactions in living cells.
Andrew Niles, an Applications Scientist from BMG LABTECH talked at SLAS 2017 about how to perform real-time, walk-away, cell-health assays.
Davin M. Henderson and Carl Peters (BMG LABTECH) talked about how to optimize sensitivity and specifity in the RT- QUiC assay using BMG LABTECH plate readers.
The speakers show the impact that working under physiological conditions can have to improve the interpretation of data.
Shanne Tillo, Carl Peters and EJ Dell, talked at SLAS 2017 about the real time detection of G-protein coupled receptors in living cells.
Real-Time Cell Health Assays Deliver Better Data with Less Effort
Steve Trim from Venomtech Ltd. presents "Novel haemoglobin modifying activity discovered through screening T-VDAcv" at the 2013 ELRIG in Manchester.
This presentation will give examples which highlight the need for ensuring sample quality and observing good experimental practices for the generation of meaningful and reliable binding data.
Applications of proteomics to cell biology and biomedical research require further developments of mass spectrometry (MS) technology to overcome long-standing limitations in speed, sensitivity and robustness.
The most common in vitro methods for immunologists to analyze cells of the immune system are flow cytometry, PCR and various forms of ELISA. Together, these enable quantification of different cell populations at the molecular and functional level (‘immuno-phenotyping’) and measurement of immune responses, for example, cytokine release.
The success of immune checkpoint blockade adds a new therapeutic category to the cancer therapy repertoire. Despite efforts made on cancer cell and immune cell interaction, how cancer cells initiate immune escape is less understood.
For the body to defend and fight against cancer, immune cells must recognize, engage, destroy and ultimately remove unwanted tumor cells. Understanding these processes at the cellular level is central to identifying and validating new immunotherapy approaches.
In this exclusive webcast of our workshop held at IMMUNOLOGY 2017™ in Washington, D.C., learn how to add real-time visualization and analysis of immune cell cultures to your in vitro assay toolkit for immunology research.
Learn long-term live cell imaging for high-content applications & learn about the new developments in image acquisition that combine live cell incubation and imaging with high-content screening approaches.
Alongside intense efforts to exploit T-cells as immunotherapies for cancer (e.g. checkpoint inhibitors, CAR-T, T-cell metabolism), researchers are increasingly considering other immune cell types for novel targets. One example is the enhancement of macrophage function via inhibitors of CD47 “don’t-eat-me” signalling proteins, enabling tumour cells to evade clearance by neighbouring phagocytes (Kim et al, 2012, Leukemia 26, 2538–2545).
The last decade has seen a significant shift in the way that mammalian cells are used in biomedical science. Researchers are increasingly turning from simple, reductionist recombinant cells to primary cells, stem-cell derived cells and advanced in vitro co-culture and organoid models for greater translation and wider application in their work.
Proteins are highly versatile macromolecules that enact a wide range of biological functions such as catalysis, regulation, communication, mechanical support, movement, and transport. At least several million unique proteins exist in the human body which are, surprisingly, encoded by only fifteen thousand genes.
How quantitative live-cell analysis has enabled the study of FMDV RNA replication out-with high bio-containment facilities.